These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Out of Africa: Increasing reports of artemether-lumefantrine treatment failures of uncomplicated Plasmodium falciparum infection. Halsey ES; Plucinski MM J Travel Med; 2023 Dec; 30(8):. PubMed ID: 38109778 [No Abstract] [Full Text] [Related]
3. Plasmodium malariae after successful treatment of P. falciparum malaria with artemether-lumefantrine. Tournoy TK; Rosanas-Urgell A; Van Esbroeck M; Bottieau E; Huits R Int J Infect Dis; 2022 Jun; 119():56-58. PubMed ID: 35358721 [TBL] [Abstract][Full Text] [Related]
4. Have You Heard the News? Artemether-lumefantrine is Now Recommended for ALL Uncomplicated Malaria in the United States, Including in Pregnancy. Castro L; Ridpath A; Mace K; Gutman JR Clin Infect Dis; 2024 Feb; 78(2):245-247. PubMed ID: 37847222 [No Abstract] [Full Text] [Related]
5. Quinine plus clindamycin vs artemether-lumefantrine for treatment of uncomplicated falciparum malaria in western Kenya. Obonyo CO; Ogutu BR Malar J; 2022 Jun; 21(1):198. PubMed ID: 35729571 [No Abstract] [Full Text] [Related]
6. Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial. Tripura R; von Seidlein L; Sovannaroth S; Peto TJ; Callery JJ; Sokha M; Ean M; Heng C; Conradis-Jansen F; Madmanee W; Peerawaranun P; Waithira N; Khonputsa P; Jongdeepaisal M; Pongsoipetch K; Chotthanawathit P; Soviet U; Pell C; Duanguppama J; Rekol H; Tarning J; Imwong M; Mukaka M; White NJ; Dondorp AM; Maude RJ Lancet Infect Dis; 2023 Jan; 23(1):81-90. PubMed ID: 36174595 [TBL] [Abstract][Full Text] [Related]
7. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652 [TBL] [Abstract][Full Text] [Related]
8. First case of treatment failure of artemether-lumefantrine in a Japanese traveler with imported falciparum malaria. Mizuno Y; Kato Y; Kudo K; Kano S Jpn J Infect Dis; 2009 Mar; 62(2):139-41. PubMed ID: 19305055 [TBL] [Abstract][Full Text] [Related]
9. Artemether-lumefantrine, mefloquine and atovaquone-proguanil in the treatment of uncomplicated Plasmodium falciparum malaria in travellers: A retrospective comparative study of efficacy and treatment failures. Grebenyuk V; Stejskal F; Nohýnková E; Zicklerová I; Richterová L; Roháčová H; Rozsypal H; Trojánek M Travel Med Infect Dis; 2023; 52():102549. PubMed ID: 36792022 [TBL] [Abstract][Full Text] [Related]
11. [Monitoring the Efficacy of Artemether-Lumefantrine in the Treatment of Uncomplicated Nambei WS; Biago U; Balizou O; Pounguinza S; Moyen M; Ndoua C; Gody JC Med Trop Sante Int; 2021 Mar; 1(1):. PubMed ID: 35586639 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria among Children in Western Kenya, 2016 to 2017. Westercamp N; Owidhi M; Otieno K; Chebore W; Buff AM; Desai M; Kariuki S; Samuels AM Antimicrob Agents Chemother; 2022 Sep; 66(9):e0020722. PubMed ID: 36036611 [TBL] [Abstract][Full Text] [Related]
13. Persistence of Residual Submicroscopic P. falciparum Parasitemia following Treatment of Artemether-Lumefantrine in Ethio-Sudan Border, Western Ethiopia. Tadele G; Jaiteh FK; Oboh M; Oriero E; Dugassa S; Amambua-Ngwa A; Golassa L Antimicrob Agents Chemother; 2022 Sep; 66(9):e0000222. PubMed ID: 35993723 [TBL] [Abstract][Full Text] [Related]
14. Lumefantrine plasma concentrations in uncontrolled conditions among patients treated with artemether-lumefantrine for uncomplicated plasmodium falciparum malaria in Mwanza, Tanzania. Marwa KJ; Liwa AC; Konje ET; Mwita S; Kamugisha E; Swedberg G Int J Infect Dis; 2022 Oct; 123():192-199. PubMed ID: 36064162 [TBL] [Abstract][Full Text] [Related]
15. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Coadministered Ruxolitinib and Artemether-Lumefantrine in Healthy Adults. Chughlay MF; Barnes KI; El Gaaloul M; Abla N; Möhrle JJ; Griffin P; van Giersbergen P; Reuter SE; Schultz HB; Kress A; Tapley P; Webster RA; Wells T; McCarthy JS; Barber BE; Marquart L; Boyle MJ; Engwerda CR; Chalon S Antimicrob Agents Chemother; 2022 Jan; 66(1):e0158421. PubMed ID: 34694880 [TBL] [Abstract][Full Text] [Related]
16. A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya. Juma EA; Obonyo CO; Akhwale WS; Ogutu BR Malar J; 2008 Dec; 7():262. PubMed ID: 19102746 [TBL] [Abstract][Full Text] [Related]
17. Descriptive study on the efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Sudan. Elamin SB; Awad AI; Eltayeb IB; Elmardi KA; Hassan AH; Mohamed AO; Malik EM; Mohamad TA Eur J Clin Pharmacol; 2010 Mar; 66(3):231-7. PubMed ID: 20187287 [TBL] [Abstract][Full Text] [Related]
18. Artemether-lumefantrine: an option for malaria. Stover KR; King ST; Robinson J Ann Pharmacother; 2012 Apr; 46(4):567-77. PubMed ID: 22496476 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial. Achan J; Tibenderana JK; Kyabayinze D; Wabwire Mangen F; Kamya MR; Dorsey G; D'Alessandro U; Rosenthal PJ; Talisuna AO BMJ; 2009 Jul; 339():b2763. PubMed ID: 19622553 [TBL] [Abstract][Full Text] [Related]
20. Sutherland CJ; Lansdell P; Sanders M; Muwanguzi J; van Schalkwyk DA; Kaur H; Nolder D; Tucker J; Bennett HM; Otto TD; Berriman M; Patel TA; Lynn R; Gkrania-Klotsas E; Chiodini PL Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28137810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]